Your session is about to expire
← Back to Search
Virtual Reality Analgesia (VRA) for Pain Control (PEDSPAINVR Trial)
N/A
Waitlist Available
Led By Yuxi Chen, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up about 20 minutes per patient
Awards & highlights
PEDSPAINVR Trial Summary
This trial is testing whether virtual reality can help reduce pain for children undergoing botulinum toxin injections for spasticity management.
PEDSPAINVR Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ about 20 minutes per patient
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~about 20 minutes per patient
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pain
Secondary outcome measures
Measurement of severity of anxiety
PEDSPAINVR Trial Design
3Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
This group of subjects will receive no intervention beyond standard sedation, anesthetic, and/or restraint-this group will serve as the control group
Group II: Google Cardboard VRAActive Control1 Intervention
This group of subjects will receive VRA intervention using Google Cardboard Virtual reality head- mounted display powered by a iPod touch.
Group III: Oculus Rift VRAActive Control1 Intervention
This group of subjects will receive VRA with Oculus Rift
Find a Location
Who is running the clinical trial?
Montefiore Medical CenterLead Sponsor
446 Previous Clinical Trials
582,719 Total Patients Enrolled
12 Trials studying Pain
3,092 Patients Enrolled for Pain
American Academy of Physical Medicine and RehabilitationOTHER
1 Previous Clinical Trials
2 Total Patients Enrolled
Yuxi Chen, MDPrincipal InvestigatorAlbert Einstein College of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Google Cardboard VRA
- Group 3: Oculus Rift VRA
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger